Inspirna Appoints Dr. Karim Benhadji as Chief Medical Officer
Key Highlights Dr. Karim Benhadji appointed as Chief Medical Officer, effective May 1, 2024. Robert Wasserman, M.D., retires and…
Browsing Tag
GV20 Therapeutics
1 post